Trwa ładowanie...
Zaloguj
Notowania

SPH acquired rights for warrants issue

Notification from "Donev investments holding" AD for Acquired rights to issue warrants under Art. 10, point 2f of Delegated Regulation (EU) 2016/522.

Załączniki

Inne komunikaty

DataTytułKursZmiana
2024-03-20
SPH Sales revenues for February 2024
14,40
-3,13
2024-03-12
SPH Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212
14,00
-1,43
2024-03-11
SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase
13,80
+1,45
2024-02-29
SPH Consolidated financial report as of 31 December 2023
13,70
-2,19
2024-02-27
SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
13,40
+2,99
2024-02-22
SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants
13,75
-0,73
2024-02-22
SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition
13,75
-0,73
2024-02-20
SPH NOTIFICATION OF INSIDERS’ TRANSACTIONS under art. 19 of Regulation 596/2014 for subscribin shares from a temporary issue/exercising warrants
14,70
-8,84
2024-02-20
SPH Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants
14,70
-8,84
2024-02-20
SPH Notification from Ognian Donev under Art. 19 of Regulation (EU) 596/2014 for subscribing sharesd form a temporary issue/exercising warrants on 19 February 2024
14,70
-7,48